Reply to Letter to the Editor: Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage

Authors

Venkatkrish M. Kasetty, Henry Ford HealthFollow
Dennis M Marcus

Recommended Citation

Kasetty VM, and Marcus DM. Reply to Letter to the Editor: Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage. Ophthalmic Surg Lasers Imaging Retina 2023; 54(10):610-611.

Document Type

Article

Publication Date

10-1-2023

Publication Title

Ophthalmic Surg Lasers Imaging Retina

Keywords

Humans, Vitrectomy, Vitreous Hemorrhage, Diabetic Retinopathy, Receptors, Vascular Endothelial Growth Factor, Diabetes Mellitus

Medical Subject Headings

Humans; Vitrectomy; Vitreous Hemorrhage; Diabetic Retinopathy; Receptors, Vascular Endothelial Growth Factor; Diabetes Mellitus

PubMed ID

37847160

Volume

54

Issue

10

First Page

610

Last Page

611